Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements
暂无分享,去创建一个
T. Fest | W. Hamadou | Z. Soua | A. Khelif | S. Besbes | Y. B. Youssef | B. Achour | M. Boulland | H. Regaieg
[1] A. Zelenetz,et al. Acute lymphoblastic leukemia. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[2] D. Parkin,et al. Trends in the incidence of cancer in the Sousse region, Tunisia, 1993–2006 , 2010, International journal of cancer.
[3] R. Hafsia,et al. Suivi de la maladie résiduelle dans les leucémies aiguës par cytométrie en flux , 2009 .
[4] T. Révész,et al. Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemia. , 2009, The Journal of molecular diagnostics : JMD.
[5] J. Wachowiak,et al. Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience , 2008, Archivum Immunologiae et Therapiae Experimentalis.
[6] M. Lefranc,et al. Chemiluminescent detection of clonal immunoglobulin and T cell receptor gene rearrangements in Tunisian lymphoid malignancies, leukemias and lymphomas , 2006, Leukemia & lymphoma.
[7] B. Nadel,et al. Unraveling the Consecutive Recombination Events in the Human IGK Locus1 , 2004, The Journal of Immunology.
[8] Marie-Paule Lefranc,et al. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor VJ and VDJrearrangement analysis , 2004, Nucleic Acids Res..
[9] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[10] J. Gabert,et al. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects , 2003, Leukemia.
[11] C. V. D. Schoot,et al. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR , 2002, Leukemia.
[12] C. Scrideli,et al. Minimal residual disease in Brazilian children with acute lymphoid leukemia: comparison of three detection methods by PCR. , 2002, Leukemia research.
[13] K. Rajewsky,et al. Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human , 2001, European journal of immunology.
[14] L. Foroni,et al. Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments. , 2001, Blood.
[15] C. V. D. Schoot,et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia , 2000, Leukemia.
[16] M. Andreeff,et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] S. Panzer,et al. Multiplex PCR reaction for the detection and identification of immunoglobulin kappa deleting element rearrangements in B‐lineage leukaemias , 1999, British Journal of Haematology.
[18] T. Szczepański,et al. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease , 1999, Leukemia.
[19] M. Kami,et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998, The Lancet.
[20] W. Hop,et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998, The Lancet.
[21] M. Stul,et al. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease , 1998, Leukemia.
[22] A Orfao,et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.
[23] J. V. van Dongen,et al. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis. , 1994, Leukemia.
[24] K. Rajewsky,et al. Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction. , 1993, The American journal of pathology.
[25] J. V. van Dongen,et al. Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[26] J. Norton,et al. Immunoglobulin gene ‘fingerprinting’: an approach to analysis of B lymphoid clonality in lymphoproliferative disorders , 1991, British journal of haematology.
[27] K. Siminovitch,et al. The human kappa deleting element and the mouse recombining segment share DNA sequence homology. , 1987, Nucleic acids research.
[28] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.
[29] C. Bartram,et al. Duplex PCR facilitates the identification of immunoglobulin kappa (IGK) gene rearrangements in acute lymphoblastic leukemia , 2000, Leukemia.
[30] I. Tomlinson,et al. The human immunoglobulin VH repertoire. , 1995, Immunology today.
[31] M. Lefranc,et al. First study of immunoglobulin and T cell receptor gene rearrangements in chronic and acute lymphoblastic leukemias from Tunisia. , 1995, Experimental and clinical immunogenetics.
[32] S. Korsmeyer,et al. A uniform deleting element mediates the loss of kappa genes in human B cells. , 1985, Nature.